ADVIA® Chemistry µALB Microalbumin Reagents 10318197Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Microalbumin - ADVIA Chem. - RGT - 4x105/4x130 tests · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414517643), received between Jan 13, 2023 and Jan 13, 2023 — classified as 1 malfunction.
The most frequently reported specific device problem is “Low Test Results” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Aug 15, 2024Class IIOpen, Classified
Atellica CH Microalbumin_2 (ALB_2) and the ADVIA Chemistry Microalbumin_2 (ALB_2) are not meeting the High-Dose Hook Effect claim/Prozone Effect claim as stated in the Instructions for Use (IFU) on the Atellica CH, Atellica CI Analyzers, ADVIA 1800 Chemistry Systems, ADVIA 2400 Chemistry Systems, and ADVIA Chemistry XPT Systems, may result in erroneously depressed microalbumin patient results.
Z-3170-2024 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
Most reported problems
Device problems
- Low Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 13, 2023Low Test Results; Low Test Results
FALSELY DEPRESSED MICROALBUMIN_2 (ALB_2) RESULTS WERE OBTAINED ON 2 PATIENT SAMPLES ON AN ATELLICA CH 930 ANALYZER, SERIAL NUMBER (S/N): (B)(4), USING ADVIA CHEMISTRY MICROALBUMIN REAGENT. THE DISCORDANT RESULTS WERE REPORTED TO THE PHYSICIAN(S). THE SAMPLES WERE REPEATED ON THE SAME ANALYZER THE FOLLOWING DAY. THE REPEAT RESULTS WERE HIGHER THAN THE DISCORDANT RESULTS. THE REPEAT RESULTS WERE REPORTED, AS THE CORRECT RESULTS, TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY DEPRESSED ALB_2 RESULTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16158731 ↗
Other INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.) devices
- Atellica CH uALB_2 11097610Siemens Healthcare Diagnostics Inc. · INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.)1 recall3 reports
- One+Step Protein 8194Dfi CO.,Ltd · Indicator Method, Protein Or Albumin (Urinary, Non-Quant.)1 recall0 reports
- DCA Vantage® Analyzer 10282969Siemens Healthcare Diagnostics Inc. · INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.)20 reports
- CLINITEK Novus® Automated Urine Chemistry Analyzer 10697937Siemens Healthcare Diagnostics Inc. · INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.)20 reports
- Tinaquant Albumin Gen2 4469658190Roche Diagnostics GmbH · INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.)18 reports
- Tina-quant Albumin Gen.2 08056722190Roche Diagnostics GmbH · INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.)11 reports
- CHEMSTRIP MICRAL URINE TEST STRIPS 11544039160Roche Diagnostics GmbH · INDICATOR METHOD, PROTEIN OR ALBUMIN (URINARY, NON-QUANT.)1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page